Home
About
Overview
Sharing Data
ORCID
Help
History (35)
Emetics
G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.
Human Body
Tobacco Industry
Engineering the nanoparticle-protein interface for cancer therapeutics.
See All 35 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Engineering the nanoparticle-protein interface for cancer therapeutics.
Saie AA, Ray M, Mahmoudi M, Rotello VM. Engineering the nanoparticle-protein interface for cancer therapeutics. Cancer Treat Res. 2015; 166:245-73.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Drug Delivery Systems
Humans
Nanoconjugates
Nanomedicine
Neoplasms
authors with profiles
Vincent Rotello PhD